Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stomach cancer
Marketing
Pharma-backed group wants patients to test their biomarkers
Stomach cancer is the fifth most commonly diagnosed cancer in the world and claims around 10,000 lives each year in the U.S.
Ben Adams
Feb 5, 2024 7:25am
FDA rejects Astellas' zolbetuximab for manufacturing issues
Jan 9, 2024 9:08am
FDA adds uses for Merck's Keytruda, Pfizer and Astellas' Xtandi
Nov 17, 2023 11:18am
Merck's Keytruda mostly won out at ESMO, with one notable miss
Oct 24, 2023 9:05am
Merck's Keytruda flunks trial in early stomach cancer
Jun 20, 2023 11:28am
Merck's Keytruda eyes updated stomach cancer label
Jun 16, 2023 11:29am